Olverembatinib Uses, Dosage, Side Effects and more
Olverembatinib is under investigation in clinical trial NCT03883100 (A Pivotal Study of Olverembatinib in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation).
| Trade Name | Olverembatinib |
| Generic | HQP1351 |
| HQP1351 Other Names | Hqp-1351 free base, Hqp1351 free base, Olverembatinib |
| Type | |
| Formula | C29H27F3N6O |
| Weight | Average: 532.571 Monoisotopic: 532.219844002 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
